                         SEQUENCE LISTING

<110>  EZYBio
 
<120>  Subject-Specific Tumor Inhibiting Cells and the Use Thereof

<130>  EZY021PCT

<140>  PCT/US2018/065578
<141>  2018-12-14

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  RNA
<213>  Homo sapiens


<220>
<221>  sgRNA
<222>  (1)..(23)

<400>  1
gagguccacc agauuagcuc ugg                                               23


<210>  2
<211>  60
<212>  DNA
<213>  Escherichia coli


<220>
<221>  Primer1
<222>  (1)..(60)

<400>  2
ttaatacgac tcactataga ggtccaccag attagctcgt tttagagcta gaaatagcaa       60


<210>  3
<211>  455
<212>  DNA
<213>  Escherichia coli


<220>
<221>  pUC57
<222>  (1)..(455)

<400>  3
tgtacaaaaa agcaggcttt aaaggaacca attcagtcga ctggatccgg taccaaggtc       60

gggcaggaag agggcctatt tcccatgatt ccttcatatt tgcatatacg atacaaggct      120

gttagagaga taattagaat taatttgact gtaaacacaa agatattagt acaaaatacg      180

tgacgtagaa agtaataatt tcttgggtag tttgcagttt taaaattatg ttttaaaatg      240

gactatcata tgcttaccgt aacttgaaag tatttcgatt tcttggcttt atatatcttg      300

tggaaaggac gaaacaccga gtgtggcgcg ggactgccgt tttagagcta gaaatagcaa      360

gttaaaataa ggctagtccg ttatcaactt gaaaaagtgg caccgagtcg gtgctttttt      420

tctagaccca gctttcttgt acaaagttgg catta                                 455


<210>  4
<211>  21
<212>  DNA
<213>  Escherichia coli


<220>
<221>  Primer2
<222>  (1)..(21)

<400>  4
aaaagcaccg actcggtgcc a                                                 21


